Lead Plaintiff Deadline is June 11, 2019

NEW YORK, April 17, 2019 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of purchasers of the securities of Zogenix, Inc. (“Zogenix” or the “Company”) (NASDAQ: ZGNX) from February 6, 2019 through April 8, 2019, inclusive (the “Class Period”).

Investors who purchased shares of Zogenix, Inc. are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website www.whafh.com.

If you have incurred losses in the shares of Zogenix, Inc., you may, no later than June 11, 2019, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in Zogenix, Inc.

## Follow the firm and learn about newly filed cases on Twitter and Facebook. ## 

According to the filed complaint, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

(1) Zogenix’s New Drug Application (“NDA”) for FINTEPLA contained inadequate non-clinical data and an incorrect version of a clinical dataset;

(2) consequently, Zogenix’s NDA for FINTEPLA was unlikely to gain FDA approval; and

(3) as a result, Zogenix’s public statements were materially false and misleading at all relevant times.

On April 8, 2019, after the close of trading, the Company announced that the federal regulator determined that the NDA was not sufficiently complete to permit a substantive review. On this news, the price of Zogenix shares fell sharply lower on April 9, 2019, closing at $39.96, down $10.89 per share.

Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.  The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego.  The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.